Hidradenitis suppurativa trials in Belgium
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Where
- Anderlecht, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years to 100 years
- People
- 710 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Anderlecht, Charleroi, Gent, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Anderlecht, Gent, Liège
- Age
- 18 years and over
- People
- 144 worldwide
- Run by
- Sanofi
See details and how to joinNCT07225569 · EU 2025-522695-83-00 - No phaseTaking peopleEstablishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)
- Where
- Leuven
- People
- 100
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT06368388 - Phase 4Taking peopleClindamycin for the treatment of infections: the influence of rifampicin and obesity on PK/PD target attainment
- Where
- Leuven
- Age
- 18 years and over
- People
- 40
- Run by
- UZ Leuven
See details and how to join2024-515872-12-00 - Phase 3Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Ghent, Leuven
- Age
- 12 years and over
- People
- 835 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to joinNCT07007637